Pender Fund Capital Management Ltd. Zynerba Pharmaceuticals, Inc. Put Options Transaction History
Pender Fund Capital Management Ltd.
- $132 Million
- Q3 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding ZYNE
# of Institutions
4Shares Held
774KCall Options Held
0Put Options Held
0About Zynerba Pharmaceuticals, Inc.
- Ticker ZYNE
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 45,753,100
- Description
- Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. The company focuses on developing pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. It is developing Zygel, a pharmaceutically-produced cannabidiol formulated as a permeation-enhanced gel for t...